Cargando…
Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation
OBJECTIVE: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective medications to reduce appetite and body weight. These actions are centrally mediated; however, the neuronal substrates involved are poorly understood. METHODS: We employed a combination of neuroanatomical, genetic, and beh...
Autores principales: | Costa, Alessia, Ai, Minrong, Nunn, Nicolas, Culotta, Isabella, Hunter, Jenna, Boudjadja, Mehdi Boutagouga, Valencia-Torres, Lourdes, Aviello, Gabriella, Hodson, David J., Snider, Brandy M., Coskun, Tamer, Emmerson, Paul J., Luckman, Simon M., D'Agostino, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689241/ https://www.ncbi.nlm.nih.gov/pubmed/34844019 http://dx.doi.org/10.1016/j.molmet.2021.101407 |
Ejemplares similares
-
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
por: Borner, Tito, et al.
Publicado: (2023) -
The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling
por: Worth, Amy A, et al.
Publicado: (2020) -
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models
por: Borner, Tito, et al.
Publicado: (2021) -
Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice
por: Ying, Zhixiong, et al.
Publicado: (2023) -
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
por: Mathiesen, David S., et al.
Publicado: (2019)